Medical device maker Boston Scientific (NYSE:BSX) acquired the fiXate tissue band from Anulex Technologies, launching the suturing system right away.
Neuromodulation/Neurostimulation
FDA approves Boston Scientific’s Precision Spectra pain relief device
Boston Scientific (NYSE:BSX) said it’s beginning a limited U.S. launch of its Precision Spectra spinal cord stimulation device now that the FDA has approved it for treating chronic pain.
The Natick, Mass.-based medical device company said the device is designed to deliver controlled electrical pulses that mask pain signals on their way to the brain.
Medtronic launches yet another back pain neurostim study
St. Jude lands 1st CE Mark for brain stim in treatment of involuntary muscle movement
St. Jude Medical (NYSE:STJ) landed CE Mark approval in the European Union for a trio of neurostimulation devices in treatment of primary and secondary dystonia, the 1st such CE Mark of its kind.
BioControl Medical makes progress toward FDA review for CardioFit heart stim device
Israel and Minnesota-based BioControl Medical won FDA approval to proceed with the 3rd and largest phase of its INOVATE-HF trail, evaluating its CardioFit vagal nerve stimulation system in treatment of heart failure.
The global, multi-center trial aims to provide clinical data in support of BioControl’s premarket approval application for FDA clearance of the CardioFit system, according to a press release.
Funding: Nevro Corp. lands $48M in support of spinal cord stimulation tech
Study: Experimental anorexia treatment with deep brain stimulation may provide lasting results
In what some are calling "a world 1st," researchers reported some success in treating severe anorexia patients via implanted electrodes that delivered electrical energy to the regions of the brain associated with emotion.
The study enrolled 6 patients to receive the experimental treatment, reporting that 3 of the 6 achieved weight gain and 4 of the 6 reported changes in mood, anxiety, control over their urges to binge and purge and other symptoms associated with anorexia.
Neuro devices maker recalls implanted electrodes over brain damage concerns
Wisconsin-based medical device maker Ad-Tech Medical Instrument Corp. launched a wide-reaching recall of its Macro Micro Subdural Electrodes over concerns that the implanted devices could cause damage to the brain.
The recall extends to devices manufactured from June 2006 to March 2012, according to an FDA notice.
Weight loss: EnteroMedics closes $13M round | Wall Street Beat
EnteroMedics (NSDQ:ETRM) said it closed a public offering it expects to add about $12 million to its coffers after it pays off expenses.
The St. Paul, Minn.-based medical device company is developing technology to treat obesity using neurostimulation of the vagus nerve to suppress the appetite.
Details on the FDA panel’s NeuroPace deliberations
An FDA advisory panel last week debated who should be allowed to implant NeuroPace’s anti-epilepsy device, where it should be implanted and which patients should be eligible for it on the way to recommending approval for the implant.
The federal watchdog agency’s Neurological Devices Advisory Panel, in a non-binding vote Feb. 22, recommended that the FDA approve NeuroPace’s RNS deep-brain stimulation therapy for certain categories of epilepsy, but had some reservations about the details
FDA panel recommends approval of NeuroPace’s anti-epilepsy implant
California neurostimulation devices maker NeuroPace crept 1 step closer to an FDA win for its epilepsy implant with near-unanimous approval from the FDA’s Neurological Devices Advisory Panel.